Followers | 283 |
Posts | 1162 |
Boards Moderated | 0 |
Alias Born | 10/04/2020 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, October 11, 2020 12:35:43 PM
Dr. Fauci
No. of Patents: 1,848
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&f=S&l=50&d=PTXT&Query=fauci
Dr. Cotropia
No. of Patents: 242
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&f=S&l=50&d=PTXT&Query=Cotropia
Based on this information proving Dr. Cotropia's world class Bio-Medical Science Research background that fundamentally is "on par" with Dr. Fauci, combined with Cotropia's superior Clone-3 Antibody Patent that clearly represents "Disruption Technology" for potential AIDS/HIV curative treatment as a Monotherapy approach for most HIV strains, and possibly Covid-19, the above is all I needed to see to make the decision to invest in Enzolytics-BioClonetics. For me it was a "no brainer", it didn't take a lot of thought because I know who these guys are!
The clinical implications of this is extraordinarily profound and the Patent Cotropia holds on Clone-3, in and of itself, and all by itself, independent of bringing it to market, is worth $$Billions$$ far beyond any AIDS/HIV drug therapies that have been commercialized for clinical application thus far.
There's nothing like this that presently exists in the marketplace.
Let me be very clear about something, both Fauci and Cotropia are world class leaders in infectious disease investigational research and treatment.
Therefore, it was an easy decision for me to invest in Enzolytics-Bioclonetics based on my own Bio-Medical Science research background in University based Academic Medicine & BigPharma Clinical Research patient trials.
Be well and prosper .....
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM